Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

The mechanistic target of rapamycin (mTOR) is a kinase whose activity is elevated in hematological malignancies. mTOR-complex-1 (mTORC1) phosphorylates numerous substrates to promote cell proliferation and survival. Eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BPs) are mTORC1 substra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bianca J., Mallya, Sharmila, Dinglasan, Nuntana, Fung, Amos, Nguyen, Tram, Herzog, Lee-or, Thao, Joshua, Lorenzana, Edward G., Wildes, David, Singh, Mallika, Smith, Jacqueline A. M., Fruman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366290/
https://www.ncbi.nlm.nih.gov/pubmed/34408976
http://dx.doi.org/10.3389/fonc.2021.673213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366290/
https://www.ncbi.nlm.nih.gov/pubmed/34408976
http://dx.doi.org/10.3389/fonc.2021.673213

Ejemplares similares